Global private equity and venture capital news and research

Posts Tagged ‘biotech’

23 October 2015

Israel Biotech targets $100m for debut fund

isr Newly formed venture capital firm Israel Biotech Fund has launched its first fund with a $100m target, AltAssets understands.

14 October 2015

Year-on-year PE, VC biotech investment jumps despite monthly slide $

tube-786932_1920 The value of private equity, venture capital and development capital investment targeting global biotechnology companies was up more than a third year-on-year in September despite a month-on-month drop.

18 August 2015

Warburg Pincus, Sutter Hill Ventures in $100m consumer-focused genome project

DNA, gene strand Warburg Pincus, the New York-based private equity firm, and Palo Alto, California's Sutter Hill Ventures are joining forces with US gene-sequencing giant Illumina to launch a new company they say will "empower consumers to discover insights into their own genomes".

17 August 2015

UK activity bolsters biotech investment from PE, VC firms $

dna-163466_1280 The value of private equity, venture capital and development capital investment in the global biotechnology sector increased for the second month in a row in July to reach its highest point of 2015 so far new research shows.

20 July 2015

Strong Canadian performance helps boost global PE, VC biotech investment $

flasks-606612_1280 Strong investment in North American biotech companies saw global private equity and venture capital backing within the sector almost double in June compared to the same time last year.

9 July 2015

Wellington Partners major backer in German biotech company’s €29m financing

microscope pixabay Wellington Partners, a venture capital firm with offices in London and Munich, was a cornerstone investor – at €5m – in a €29m financing round at Munich-based biotech company 4SC AG.

8 July 2015

LSP-backed Dutch biotech company Kiadis Pharma raises €33m in IPO

biotech lab clinic research VC-backed Kiadis Pharma has raised €33m after becoming the first Dutch biotech company to list on Euronext Amsterdam in five years.

23 June 2015

New Leaf collects $200m for first Growth Fund

leaf-654121_640 New Leaf Venture Partners has reportedly closed its first dedicated growth fund on $200m, AltAssets understands.

27 May 2015

CITIC-backed 3SBIO launches $712m Hong Kong IPO

syringe-m Private equity-backed Chinese biotech company 3SBIO has launched an up to $712m IPO.

21 May 2015

Vivo Capital, Venrock help gene therapy business Regenxbio to weighty $70.5m Series D

microscope pic Gene therapy-focused biotech business Regenxbio has closed a hefty $70.5m Series D financing round thanks to investment from firms including Vivo Capital and Venrock.

Page 1 of 1312345...10...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015